Endocytosis of Hepatitis B Immune Globulin into Hepatocytes Inhibits the Secretion of Hepatitis B Virus Surface Antigen and Virions

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Virology

• Publication date

  2003-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.77.16.8882-8892.2003PMID 12885906PMCID PMC167249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte Membrane‐Bound IgG and Circulating Liver‐Specific Autoantibodies in Chronic Liver Disease: Relation to Hepatitis B Virus Serum Markers and Liver Histology

  2007cited by this paper
• MHC Class I-Related Neonatal Fc Receptor for IgG Is Functionally Expressed in Monocytes, Intestinal Macrophages, and Dendritic Cells1

  2001cited by this paper
• Duck Hepatitis B Virus Replication in Primary Bile Duct Epithelial Cells

  2001cited by this paper
• Novel immunoassay for the detection of hepatitis B surface ‘escape’ mutants and its application in liver transplant recipients

  2001cited by this paper
• A dominant hepatitis B virus population defective in virus secretion because of several S‐gene mutations from a patient with fulminant hepatitis

  2001cited by this paper
• Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

  2001cited by this paper
• Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays

  2000cited by this paper
• Multiple roles for the major histocompatibility complex class I- related receptor FcRn.

  2000cited by this paper
• Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

  2000cited by this paper
• Intracellular expression of a cloned antibody fragment interferes with hepatitis B virus surface antigen secretion.

  1999cited by this paper
• Detection of duck hepatitis B virus replicative markers in primary cultures of bile duct epithelial cells

  1999cited by this paper
• Characterization of the reactivity pattern of murine monoclonal antibodies against wild‐type hepatitis B surface antigen to g145r and other naturally occurring “a” loop escape mutations

  1999cited by this paper
• Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin.

  1999cited by this paper
• Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high‐dose hepatitis B immune globulin after liver transplantation

  1998cited by this paper
• Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis

  1998cited by this paper
• Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication

  1997cited by this paper
• Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture.

  1997cited by this paper
• Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.

  1997cited by this paper
• Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin

  1996cited by this paper
• The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

  1996cited by this paper
• Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

  1996cited by this paper
• A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes.

  1995cited by this paper
• Envelope and precore/core variants of hepatitis B virus.

  1994cited by this paper
• Envelope and precore/core variants of hepatitis B virus.

  1994cited by this paper
• Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal.

  1994cited by this paper
• Liver transplantation in European patients with the hepatitis B surface antigen.

  1993cited by this paper
• Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.

  1992cited by this paper
• Intracellular neutralization of virus by immunoglobulin A antibodies.

  1992cited by this paper
• Vaccine-induced escape mutant of hepatitis B virus.

  1990cited by this paper
• Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection

  1984cited by this paper
• Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

  1977cited by this paper
• The fate of injected human IgG in the mouse liver

  1975cited by this paper

• The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus

  2025cites this paper
• Prophylaxis of HBV reinfection and disease in liver transplanted patients: 2024 update on the role of HBIG and cost-effectiveness evaluation.

  2025cites this paper
• New facet of CARs: HBV-specific CARs as inhibitors of virus morphogenesis and release

  2024cites this paper
• Inonu University Experience in Hepatitis B Recurrence After Liver Transplantatio

  2024cites this paper
• Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure

  2024cites this paper
• Vaccine escape challenges virus prevention: The example of two vaccine‐preventable oncogenic viruses

  2023cites this paper
• Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion

  2023cites this paper
• Entecavir Combined With Short-term Hepatitis B Immunoglobulin in Preventing Hepatitis B Virus Recurrence in Liver Transplant Recipients.

  2023cites this paper
• Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro

  2022cites this paper
• Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy

  2022cites this paper
• A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

  2022cites this paper
• Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.

  2021cites this paper
• Hepatitis B immunoglobulin inhibits the secretion of HBV via antigen-antibody precipitation in the multivesicular body.

  2021cites this paper
• State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection

  2021cites this paper
• Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV

  2021cites this paper
• B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection

  2021cites this paper
• Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma

  2020cites this paper
• The role of hepatitis B surface antibodies in HBV infection, disease and clearance

  2020cites this paper
• Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti‐virals

  2020cites this paper
• The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV‐related diseases in the era of potent nucleos(t)ide analogues: A meta‐analysis

  2020cites this paper
• Prevention of HBV Recurrence after Liver Transplant: A Review

  2020cites this paper
• Defective circulating and intrahepatic B cells in chronic HBV

  2019cites this paper
• Tenofovir plus Hepatitis B Immunoglobulin Treatment Resulted in a Rapid HBV DNA Load Decline in High-Risk Pregnant Women who Missed the Optimal Time Window of Antiviral Prophylaxis

  2019cites this paper
• An E. coli‐produced single‐chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion

  2019cites this paper
• Study of the distribution of hepatitis B immunoglobulin in pregnant mice using small‐animal imaging technology

  2019cites this paper
• Restoring, releasing or replacing adaptive immunity in chronic hepatitis B

  2019cites this paper
• Circulating and intrahepatic antiviral B cells are defective in hepatitis B

  2018cites this paper
• Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globülin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients.

  2018cites this paper
• Viral envelope-specific antibodies in chronic hepatitis B virus infection.

  2018cites this paper
• Hepatitis B and liver transplantation

  2018influential citation
• Interaction of S17 Antibody with the Functional Binding Region of the Hepatitis B Virus Pre-S2 Epitope

  2018cites this paper
• PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection

  2018cites this paper
• Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation

  2016cites this paper
• The Management of Hepatitis B in Liver Transplant Recipients.

  2016cites this paper
• Update on occult hepatitis B virus infection

  2016cites this paper
• The Basis for Antiviral Therapy: Drug Targets, Cross-Resistance, and Novel Small Molecule Inhibitors

  2016cites this paper
• High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.

  2016cites this paper
• Role of RNA secondary structure in emergence of compartment specific hepatitis B virus immune escape variants

  2016cites this paper
• Hepatitis B immune globulin and HBV-related liver transplantation.

  2016cites this paper
• HBV Disease Spectrum and OBI

  2015cites this paper
• Immune-mediated Liver Injury in Hepatitis B Virus Infection

  2015cites this paper
• Low‐dose short‐term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post‐transplant hepatitis B virus prophylaxis?

  2015cites this paper
• The neonatal Fc receptor does not modulate hepatitis C virus neutralization.

  2015cites this paper
• Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris*

  2015cites this paper
• Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin

  2015cites this paper
• A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity

  2015cites this paper
• Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence

  2015cites this paper
• The multiple facets of FcRn in immunity

  2015cites this paper
• Adaptive Immunity and Inflammation

  2015cites this paper
• Prevention of Post-transplant HBV

  2015cites this paper
• Safe and cost-effective control of post-transplantation recurrence of hepatitis B

  2014cites this paper
• Naked Viruses That Aren't Always Naked: Quasi-Enveloped Agents of Acute Hepatitis.

  2014cites this paper
• Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients

  2014cites this paper
• Hepatitis B virus replication and integration

  2014cites this paper
• Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C

  2014cites this paper
• HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation

  2014cites this paper
• A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity

  2013influential citation
• Management of Hepatitis B Virus Infection in Liver Transplant Recipients

  2013cites this paper
• Outcome of Various Treatments for Posttransplant Hepatitis B Virus Recurrence

  2013cites this paper
• Prophylaxis of hepatitis B infection in solid organ transplant recipients

  2013cites this paper
• Molecular Mechanisms Underlying Occult Hepatitis B Virus Infection

  2012cites this paper
• Biology of Gut Immunoglobulins

  2012cites this paper
• Protective hepatitis B surface antibodies in blood and ascites fluid in the early stage after liver transplantation for hepatitis B diseases

  2012cites this paper
• Hepatitis B immune globulin for preventing hepatitis B recurrence after liver transplantation

  2012cites this paper
• The option of HBIG-free prophylaxis against recurrent HBV.

  2012cites this paper
• Hepatitis B Precore Protein: Pathogenic Potential and Therapeutic Promise

  2012cites this paper
• Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody.

  2011cites this paper
• Hepatitis B immunoglobulin for prevention of hepatitis B virus infection and recurrence after liver transplantation

  2011cites this paper
• The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper.

  2011cites this paper
• Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype

  2011cites this paper
• Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells

  2010cites this paper
• Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.

  2010cites this paper
• Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen–positive liver grafts receiving hepatitis B immunoglobulins

  2010cites this paper
• The possible role of myosin light chain in myoblast proliferation.

  2009cites this paper
• Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R Mutation

  2009cites this paper
• Hepatitis B Virus

  2009cites this paper
• Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen–positive liver donation: A survey of North American, European, and Asian‐Pacific transplant programs

  2009cites this paper
• Hepatitis B immune globulin and HBV-related liver transplantation

  2008cites this paper
• ENFERMEDADES DE TRANSMISIÓN SEXUAL: ESTADO ACTUAL EN EL CASO DEL VIRUS DE LA HEPATITIS B Y C. Concepción García Luján, Aurora Martínez Romero, Jesús Vásquez Arroyo y Aurelio

  2008cites this paper
• Enfermedades de transmisión sexual: estado actual en el caso del virus de la Hepatitis B y C

  2008cites this paper
• Hepatitis B immune globulin.

  2007cites this paper
• Dynamics of a hepatitis B virus e antigen minus population ascribed to genotype F during the course of a chronic infection despite the presence of anti-HBs antibodies.

  2007cites this paper
• Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.

  2007cites this paper
• Short-Term High-Dose Followed by Long-Term Low-Dose Hepatitis B Immunoglobulin and Lamivudine Therapy Prevented Recurrent Hepatitis B After Liver Transplantation

  2007cites this paper
• Review: hepatitis B immune globulin for prevention of hepatitis B infection

  2007cites this paper
• CHAPTER 43 – Biology of Gut Immunoglobulins

  2006cites this paper
• Prevention of hepatitis B virus recurrence after liver transplantation

  2006cites this paper
• Unusual Naturally Occurring Humoral and Cellular Mutated Epitopes of Hepatitis B Virus in a Chronically Infected Argentine Patient with Anti-HBs Antibodies

  2006cites this paper
• Detection of Hepatitis B Virus (HBV) Genotype E Carried—Even in the Presence of High Titers of Anti-HBs Antibodies—by an Argentinean Patient of African Descent Who Had Received Vaccination against HBV

  2006cites this paper
• Generation and characterization of a single‐gene mouse–human chimeric antibody against hepatitis B surface antigen

  2006cites this paper
• Study of IgG Subclass Profiles of Anti-HBs in Populations With Different HBV Infection Status

  2006cites this paper
• Production and characterization of recombinant human anti-HBs Fab antibodies.

  2005cites this paper
• Hepatitis B and liver transplantation.

  2005cites this paper
• HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

  2005cites this paper
• The use of HBsAg–positive organ donors: Far more than meets the eye?

  2005cites this paper
• Hepatitis B NAT virus‐positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA

  2005cites this paper
• Hepatitis C virus particles and lipoprotein metabolism.

  2005cites this paper
• Hepatitis C Virus Particles and Lipoprotein Metabolism

  2005cites this paper
• Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen

  2004cites this paper
• Prevention of HBV reactivation from anti-HBc-positive liver grafts: searching for the consensus.

  2004cites this paper